BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 19013008)

  • 1. The evolving role of oestrogens and their receptors in the development and progression of prostate cancer.
    Bonkhoff H; Berges R
    Eur Urol; 2009 Mar; 55(3):533-42. PubMed ID: 19013008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression.
    Bonkhoff H
    Prostate; 2018 Jan; 78(1):2-10. PubMed ID: 29094395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of oestrogen receptor-alpha and oestrogen receptor-beta in prostate cancer.
    Yang GS; Wang Y; Wang P; Chen ZD
    Chin Med J (Engl); 2007 Sep; 120(18):1611-5. PubMed ID: 17908481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestrogen modulates cardiac ischaemic remodelling through oestrogen receptor-specific mechanisms.
    Babiker FA; Lips DJ; Delvaux E; Zandberg P; Janssen BJ; Prinzen F; van Eys G; Grohé C; Doevendans PA
    Acta Physiol (Oxf); 2007 Jan; 189(1):23-31. PubMed ID: 17280554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative studies of the expression of estrogen receptor-alpha and estrogen receptor-beta in prostatic carcinoma].
    Yang GS; Chen ZD
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1111-5. PubMed ID: 15498298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates.
    Ho SM
    J Cell Biochem; 2004 Feb; 91(3):491-503. PubMed ID: 14755680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of estrogens in development of prostate cancer.
    Härkönen PL; Mäkelä SI
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):297-305. PubMed ID: 15663993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogens and epithelial ovarian cancer.
    Cunat S; Hoffmann P; Pujol P
    Gynecol Oncol; 2004 Jul; 94(1):25-32. PubMed ID: 15262115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposing roles of ERα and ERβ in the genesis and progression of adenocarcinoma in the rat ventral prostate.
    Attia DM; Ederveen AG
    Prostate; 2012 Jun; 72(9):1013-22. PubMed ID: 22025007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potential paradox in prostate adenocarcinoma progression: oestrogen as the initiating driver.
    Singh PB; Matanhelia SS; Martin FL
    Eur J Cancer; 2008 May; 44(7):928-36. PubMed ID: 18381236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells.
    Chen M; Ni J; Chang HC; Lin CY; Muyan M; Yeh S
    Carcinogenesis; 2009 May; 30(5):841-50. PubMed ID: 19126643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From pathogenesis to prevention of castration resistant prostate cancer.
    Bonkhoff H; Berges R
    Prostate; 2010 Jan; 70(1):100-12. PubMed ID: 19760632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Implications of estrogens and their receptors for the development and progression of prostate cancer].
    Bonkhoff H; Fixemer T
    Pathologe; 2005 Nov; 26(6):461-8. PubMed ID: 16220300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
    De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
    Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer.
    Ho SM; Leung YK; Chung I
    Ann N Y Acad Sci; 2006 Nov; 1089():177-93. PubMed ID: 17261766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
    Walton TJ; Li G; McCulloch TA; Seth R; Powe DG; Bishop MC; Rees RC
    Prostate; 2009 Jun; 69(8):810-9. PubMed ID: 19189301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pro-tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment.
    Ellem SJ; Taylor RA; Furic L; Larsson O; Frydenberg M; Pook D; Pedersen J; Cawsey B; Trotta A; Need E; Buchanan G; Risbridger GP
    J Pathol; 2014 Sep; 234(1):86-98. PubMed ID: 25042571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis.
    Kasper S
    J Cell Biochem; 2005 Feb; 94(2):279-97. PubMed ID: 15565647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.